Effects of Long-Term Exposure to Nicotinamide and Sodium Butyrate on Growth, Viability, and the Function of Clonal Insulin Secreting Cells

Endocrine Research

Volumn 30, Issue 1, 2004, Pages 61-68

  Liu, Hui Kang ^a,b   Green, Brian D ^a   Flatt, Peter R ^a   McClenaghan, Neville H ^a   McCluskey, Jane T ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Butyrate; Insulin secretion; Nicotinamide; Pancreatic beta cell function

Indexed keywords

ALANINE; BUTYRIC ACID; CALCIUM ION; FORSKOLIN; GLUCOSE; INSULIN; NICOTINAMIDE; PHORBOL 13 ACETATE 12 MYRISTATE; POTASSIUM CHLORIDE;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; HORMONE RELEASE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; LONG TERM EXPOSURE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BUTYRATES; CELL DIVISION; CELL SURVIVAL; CLONE CELLS; DIABETES MELLITUS, TYPE 1; GLUCOSE; INSULIN; ISLETS OF LANGERHANS; NIACINAMIDE; RATS; TIME FACTORS;

EID: 1842533604     PISSN: 07435800     EISSN: None     Source Type: Journal    
DOI: 10.1081/ERC-120028485     Document Type: Article

References (17)

1. Gale EA. Intervening before the onset of Type 1 diabetes: baseline data from the European Nicotinamide Diabetes Intervention Trial (ENDIT). Diabetologia 2003; 46(3):339-346.
2. Kolb H, Burkart V. Nicotinamide in type 1 diabetes. Mechanism of action revisited. Diabetes Care 1999; 22(suppl. 2):B16-B20.
3. Korsgren O, Andersson A, Sandler S. In vitro screening of putative compounds inducing foetal porcine pancreatic beta-cell differentiation: implications for cell transplantation in insulin-dependent diabetes mellitus. Ups J Med Sci 1993; 98(1):39-52.
4. Sjoholm A, Korsgren O, Andersson A. Polyamine requirements in nicotinamide-stimulated beta-cell differentiation in foetal porcine islet-like cell clusters. Endocrinology 1994; 135(4):1559-1565.
5. Otonkoski T, Mally MI, Hayek A. Opposite effects of beta-cell differentiation and growth on reg expression in human foetal pancreatic cells. Diabetes 1994; 43(9):1164-1166.
6. Otonkoski T, Ustinov J, Huotari MA, Kallio E, Hayry P. Nicotinamide and sodium butyrate for the induction of foetal porcine beta-cell differentiation prior to transplantation. Transplant Proc 1997; 29(4):2045.
7. Sandler S, Hellerstrom C, Eizirik DL. Effects of nicotinamide supplementation on human pancreatic islet function in tissue culture. J Clin Endocrinol Metab 1993; 77(6):1574-1576.
8. Silver K, Yao F. ARIP cells as a model for pancreatic beta cell growth and development. Pancreas 2001; 22(2):141-147.
9. Tuch BE, Madrid JC. Development of foetal sheep pancreas after transplantation into athymic mice. Cell Transplant 1996; 5(4):483-489.
10. Tiedge M, Lenzen S. Effects of sodium butyrate on glucose transporter and glucose-phosphorylating enzyme gene expression in RINm5F insulinoma cells. J Mol Endocrinol 1996; 17(1):19-26.
11. Bartholomeusz RK, Campbell IL, Harrison LC. A2B5-reactive ganglioside expression determines the differentiation stage and capacity of rat insulinoma (RIN) sublines. Cell Differ Dev 1990; 32(1):39-46.
12. Fernandez Mejia C, Davidson MB. Effect of sodium butyrate on glucose transport and glucose-phosphorylating enzymes in RIN-m5F cells. Pancreas 1993; 8:589-596.
13. Lee S, Clark SA, Gill RK, Christakos S. 1,25-Dihydroxyvitamin D3 and pancreatic beta-cell function: vitamin D receptors, gene expression, and insulin secretion. Endocrinology 1994; 134(4):1602-1610.
14. Huotari MA, Palgi J, Otonkoski T. Growth factor-mediated proliferation and differentiation of insulin-producing INS-1 and RINm5F cells: identification of betacellulin as a novel beta-cell mitogen. Endocrinology 1998; 139:1494-1499.
15. Otonkoski T, Ustinov J, Rasilainen S, Kallio E, Korsgren O, Hayry P. Differentiation and maturation of porcine foetal islet cells in vitro and after transplantation. Transplantation 1999; 68(11):1674-1683.
16. McClenaghan NH, Barnett CR, Ah Sing E, Abdel Wahab YHA, O'Harte FPM, Yoon TW, Swanston Flatt SK, Flatt PR. Characterization of a novel glucose-responsive insulin-secreting cell line, BRIN-BD11, produced by electrofusion. Diabetes 1996; 45(8):1132-1140.
17. Flatt PR, Bailey CJ. Abnormal plasma glucose and insulin responses in heterozygous(ob/+) mice. Diabetologia 1981; 20(5):573-577.